Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report

In the global context of the COVID-19 pandemic, the overall benefits of getting any COVID-19 vaccine approved by the World Health Organization for emergency use outweigh the potential risks, even in people with weakened immune systems, including people living with HIV (PLWH). At present, there are n...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Guang, Tang, Jie, Feng, Shuidong, Xu, Liumei, Wang, Xiaohui, Yang, Zhengrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746420/
https://www.ncbi.nlm.nih.gov/pubmed/36048127
http://dx.doi.org/10.1080/21645515.2022.2110799
_version_ 1784849355207868416
author Zeng, Guang
Tang, Jie
Feng, Shuidong
Xu, Liumei
Wang, Xiaohui
Yang, Zhengrong
author_facet Zeng, Guang
Tang, Jie
Feng, Shuidong
Xu, Liumei
Wang, Xiaohui
Yang, Zhengrong
author_sort Zeng, Guang
collection PubMed
description In the global context of the COVID-19 pandemic, the overall benefits of getting any COVID-19 vaccine approved by the World Health Organization for emergency use outweigh the potential risks, even in people with weakened immune systems, including people living with HIV (PLWH). At present, there are no reports of HIV/hepatitis B virus (HBV) co-infected patients receiving a booster dose of the inactivated COVID-19 vaccine. Here, we describe a patient with HIV/HBV co-infection who did not seroconvert to three doses of the inactivated COVID-19 vaccine.
format Online
Article
Text
id pubmed-9746420
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97464202022-12-14 Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report Zeng, Guang Tang, Jie Feng, Shuidong Xu, Liumei Wang, Xiaohui Yang, Zhengrong Hum Vaccin Immunother Coronavirus – Case Report In the global context of the COVID-19 pandemic, the overall benefits of getting any COVID-19 vaccine approved by the World Health Organization for emergency use outweigh the potential risks, even in people with weakened immune systems, including people living with HIV (PLWH). At present, there are no reports of HIV/hepatitis B virus (HBV) co-infected patients receiving a booster dose of the inactivated COVID-19 vaccine. Here, we describe a patient with HIV/HBV co-infection who did not seroconvert to three doses of the inactivated COVID-19 vaccine. Taylor & Francis 2022-09-01 /pmc/articles/PMC9746420/ /pubmed/36048127 http://dx.doi.org/10.1080/21645515.2022.2110799 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Coronavirus – Case Report
Zeng, Guang
Tang, Jie
Feng, Shuidong
Xu, Liumei
Wang, Xiaohui
Yang, Zhengrong
Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
title Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
title_full Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
title_fullStr Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
title_full_unstemmed Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
title_short Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
title_sort failure to seroconvert after three doses of inactivated covid-19 vaccines in a patient co-infected with hbv and hiv: a case report
topic Coronavirus – Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746420/
https://www.ncbi.nlm.nih.gov/pubmed/36048127
http://dx.doi.org/10.1080/21645515.2022.2110799
work_keys_str_mv AT zengguang failuretoseroconvertafterthreedosesofinactivatedcovid19vaccinesinapatientcoinfectedwithhbvandhivacasereport
AT tangjie failuretoseroconvertafterthreedosesofinactivatedcovid19vaccinesinapatientcoinfectedwithhbvandhivacasereport
AT fengshuidong failuretoseroconvertafterthreedosesofinactivatedcovid19vaccinesinapatientcoinfectedwithhbvandhivacasereport
AT xuliumei failuretoseroconvertafterthreedosesofinactivatedcovid19vaccinesinapatientcoinfectedwithhbvandhivacasereport
AT wangxiaohui failuretoseroconvertafterthreedosesofinactivatedcovid19vaccinesinapatientcoinfectedwithhbvandhivacasereport
AT yangzhengrong failuretoseroconvertafterthreedosesofinactivatedcovid19vaccinesinapatientcoinfectedwithhbvandhivacasereport

Ejemplares similares